\
&
Contact us
\
&
Contact us
This was 7 months ago
LocationRotterdam Science Tower in the Netherlands
ProgrammesYoung professionals and aspiring entrepreneurs are invited to participate in the 1st Benelux Space Startup Competition (SSC), taking place on May 1–2, 2025, at the Rotterdam Science Tower in the Netherlands.
Organized by the Space Generation Advisory Council (SGAC), this two-day event offers participants the chance to develop and pitch space-related business ideas, receive mentorship from industry experts, and present their concepts to a panel of investors and professionals.
SGAC is a non-governmental organization that supports the United Nations Programme on Space Applications and represents university students and young space professionals to the United Nations, national governments, space agencies, industry, and academia. With over 29,000 members in 170+ countries, SGAC empowers the next generation of space leaders through events, projects, and capacity-building initiatives.
Event links:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
